Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
• NP432023.RAAU0NLsj2jGFJPBqxl-ZMqtdaWjSt-R7X2LqRtbokv5g130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432023.RAAU0NLsj2jGFJPBqxl-ZMqtdaWjSt-R7X2LqRtbokv5g130_provenance.
• NP879624.RAP2Cz3wJMbCbSwZ2qdAaN2U-lzoW9VYHoxUgEqpTd860130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879624.RAP2Cz3wJMbCbSwZ2qdAaN2U-lzoW9VYHoxUgEqpTd860130_provenance.
• NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432025.RAYsJqTbLOF1c942Qohr6ohfiteEBWibfgsaC3NuLFNHM130_provenance.
• NP432026.RAW1Lkpy_sqHYWkOocdyR-61D3tAwVkHCXvErdH1gLNJk130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432026.RAW1Lkpy_sqHYWkOocdyR-61D3tAwVkHCXvErdH1gLNJk130_provenance.
• assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP432028.RAI6x-3sIayjdur1u8eQ706ImAZMkc_23yKqDzxkKGwSs130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432028.RAI6x-3sIayjdur1u8eQ706ImAZMkc_23yKqDzxkKGwSs130_provenance.
• NP638571.RAnTZhdH2GHnFuPd5GGOPblYSR5k2QempX84gHXd76WdU130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638571.RAnTZhdH2GHnFuPd5GGOPblYSR5k2QempX84gHXd76WdU130_provenance.
• NP638583.RAqaPjEolxdpj02aSu0kVKURF1RXIOon8uk4FRKojZhhg130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638583.RAqaPjEolxdpj02aSu0kVKURF1RXIOon8uk4FRKojZhhg130_provenance.